Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.

Yendt, Edmund R; Kovacs, Katherine A; Jones, Glenville

Yendt, Edmund R; Kovacs, Katherine A; Jones, Glenville.

Affiliation

Yendt ER; Department of Medicine, Queen's University, Kingston, Ontario, Canada. yendt@bellnet.ca

Clin Endocrinol (Oxf) ; 69(6): 855-63, 2008 Dec.

Article in En | MEDLINE | ID: mdl-18419790

Subject(s)

25-Hydroxyvitamin D 2/administration & dosage; Bone Diseases, Metabolic/drug therapy; Calcium, Dietary/administration & dosage; Calcium/administration & dosage; Hyperparathyroidism, Secondary/diet therapy; Osteoporosis/diet therapy; Vitamin D/administration & dosage; 25-Hydroxyvitamin D 2/blood; Alkaline Phosphatase/blood; Calcium/blood; Calcium/metabolism; Calcium Citrate/therapeutic use; Cholecalciferol/administration & dosage; Creatinine/blood; Female; Humans; Parathyroid Hormone/blood; Phosphates/blood; Retrospective Studies; Vitamin D/metabolism; Vitamin D/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Vitamin D / Bone Diseases, Metabolic / Calcium, Dietary / 25-Hydroxyvitamin D 2 / Calcium / Hyperparathyroidism, Secondary Type of study: Observational_studies / Prognostic_studies Language: En Journal: Clin Endocrinol (Oxf) Year: 2008 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google